Anika Therapeutics (ANIK) Tops Q3 EPS by 35c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $21.03 +0.91%
Revenue Growth %: +5.5%
Financial Fact:
Net income: 8.95M
Today's EPS Names:
ALZN, ASPU, USAU, More
Revenue Growth %: +5.5%
Financial Fact:
Net income: 8.95M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Anika Therapeutics (NASDAQ: ANIK) reported Q3 EPS of $0.00, $0.35 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $41.5 million versus the consensus estimate of $38.27 million.
For earnings history and earnings-related data on Anika Therapeutics (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s said to plan value strategy overhaul to revive US sales growth
- RBC bullish on Kraft Heinz, sees return to growth in 2027
- Forgent Power Solutions, Inc. (FPS) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY27 Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
